Emergency Use Authorizations (EUAs)
This page lists products that the FDA has authorized for emergency use in response to the COVID-19 public health emergency, including:
- Diagnostic and antibody tests
- Personal protective equipment
- Ventilators and other medical devices
- Drugs and biological products
This video provides a brief overview of EUAs.
Personal Protective Equipment (PPE)
The FDA has taken numerous actions to help increase supplies of medical equipment needed to fight COVID-19 and protect healthcare workers. The FDA has issued emergency use authorizations for PPE and shared answers to frequently asked questions, and recommendations for health professionals detailing conservation strategies for respirators, surgical masks, gowns and gloves:
Please note that FDA does not purchase or distribute medical supplies, such as surgical masks, respirators, or other medical devices; maintain a list of suppliers for these devices; or provide specifications for medical devices. Please also note that FDA does not consider face masks to be PPE. As described in the Face Mask EUA, face masks are only authorized for use as source control during the COVID-19 emergency.
Medical Products
Testing
Coronavirus Testing Basics provides general information about the types of available tests for SARS-CoV-2, the virus that causes COVID-19 and may be helpful for your patients to understand what they are being tested for, how they will be tested, and what their result means. For more detailed information about testing, including links to additional information, see our page for health professionals and industry.
Drug Products
At this time, there are no FDA-approved drug products to treat COVID-19, but the FDA has issued EUAs for drugs that may be used to treat COVID-19 given that there are currently no approved alternatives. Each EUA has factsheets for health care providers and patients/caregivers and information on how to obtain the drug and currently available data.
Health Professionals can help support the development of new potential treatments for COVID-19 through participating in crowdsourcing of medical information. The CURE ID app allows clinicians to quickly and easily report their experiences treating COVID-19 patients and patients with other difficult-to-treat diseases.
Investigational COVID-19 Convalescent Plasma Under EUA and IND
Convalescent plasma from individuals who have recovered from COVID-19 has not been approved for use by FDA, so it is regulated as an investigational product. This product may also be used in hospitalized COVID-19 patients under an Emergency Use Authorization. Recommendations for Investigational COVID-19 Convalescent Plasma describes other pathways health professionals can use for investigational COVID-19 convalescent plasma. Access our toolkit with fact sheet, newsletter and social media posts in English and Spanish.
Investigational Use of Antivirals
In addition to remdesivir (which has been authorized by FDA for emergency use), other antiviral products are being tested in clinical trials for safety and efficacy against COVID-19. Please email druginfo@fda.hhs.gov or call 855-543-3784 if you are would like to request an Emergency Investigational New Drug Applications (EIND) application for antiviral products.
Ventilators and Other Medical Devices
FDA has authorized emergency use of ventilators and other medical products during COVID-19. FDA has also issued recommendations for health care providers to help increase availability of ventilators.
FDA has authorized emergency use of ventilators and other medical products during COVID-19. FDA has also issued recommendations for health care providers to help increase availability of ventilators.
Fraudulent Products
FDA is actively monitoring the market for any individuals and companies selling products with fraudulent claims to diagnose, treat, prevent, or cure COVID-19. Help protect patients and find out how to report a fraudulent product or view warning letters sent to sellers.
Patient Outreach Toolkit
Working together with health care organizations and other partners across the U.S., FDA is committed to slowing the spread and meeting the challenge of COVID-19. Below are some useful resources to share with your patients and others in your community.
Unfortunately, some people and companies are trying to profit from the challenge of this pandemic by selling unproven products that make false claims, such as being effective against COVID-19. This factsheet provides tips to help spot misleading claims and how to report fraudulent products to the FDA.
Learn more about FDA’s critical role in the COVID-19 pandemic response.
Tweets about COVID-19, fraudulent COVID-19 products, medical countermeasures, prevention, and multicultural resources are available to share with your members.
Additional Information
- An overview of FDA’s response: Coronavirus Disease 2019 (COVID-19)
- For patients and caregivers:
- Report adverse events or side effects to FDA's MedWatch Safety Information and Adverse Event Reporting Program.
- Read the most recent Medical Device Safety Letters to health care professionals
- The CDC has additional information for healthcare professionals.
- The Critical Role of Health Care Professionals during COVID-19: A video conversation with health care practitioners
.png)
No hay comentarios:
Publicar un comentario